CEO Larry Ellison’s claims that artificial intelligence (AI) could help develop messenger RNA-based (mRNA) vaccines to cure cancer. We’ve all heard such blusterous aspirational hype before, to be sure.

The AI race took another geopolitical twist last past week, as the Trump Administration announced the formation of the $500 billion Project

We recently published an article titled Jim Cramer Discusses These 18 Stocks & President Trump’s $500 Billion AI Plan. In this article, we are going to take a look at where Oracle Corporation (NYSE:ORCL) stands against the other stocks Jim Cramer recently discussed.

Larry Ellison unveiled plans for an AI-driven cancer vaccine system that could deliver personalized treatments within 48 hours.

Chairman Larry Ellison highlighted the AI's potential in the development of mRNA-based cancer vaccines. Read more here.

The effort was described as a $500 billion investment in artificial intelligence. Read how a small Texas city with a population of about 130,000 fits into the plans.

As Oracle (ORCL) joins the Stargate Project, a new $500B AI infrastructure initiative, are there risks to Microsoft (MSFT) - OpenAI partnership. Read more here.

President Donald Trump said he is in favor of Elon Musk or Larry Ellison buying TikTok as he offered his latest thinking on what a deal might look like to save the US operations of the social media platform.

President Donald Trump expressed openness to Tesla CEO Elon Musk or Oracle Chairman Larry Ellison acquiring TikTok.

Oracle (NYSE:ORCL) has rallied by more than 7% upon President Trump’s recently announced $500 billion AI infrastructure investment. The news has caused many AI stocks, like Oracle, to outpace the S&P 500 today.

Moderna (MRNA) stock surged 7% this week following Oracle (ORCL) CEO Larry Ellison’s claims that artificial intelligence (AI) could help develop messenger RNA-based (mRNA) vaccines to cure cancer.

Shares of Grail, a maker of early-detection cancer screening tests, soared last week. Here are the key chart levels to watch.